NCT03765554View on ClinicalTrials.gov

Clinical Study to Evaluate Blood Concentrations of PF-06700841 After Oral Dose as Different Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

January 7, 2019

Primary Completion Date

April 3, 2019

Study Completion Date

April 3, 2019

Conditions
Healthy Participants
Interventions
DRUG

PF-06700841 Immediate release tablets

Small molecule tablets in immediate release form

DRUG

PF-06700841 Modified release tablets

Small molecule tablets in modified release form

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT03765554 - Clinical Study to Evaluate Blood Concentrations of PF-06700841 After Oral Dose as Different Formulations | Biotech Hunter | Biotech Hunter